Alban Ziegler

Dr. Alban Ziegler is a French medical geneticist trained in medical genetics in France. He completed his externship in Nancy, followed by a medical genetics residency at the University Hospital of Angers. He then held positions as a clinical genetics specialist at Le Mans Hospital and the Reference Center for Deafness at Necker Hospital in Paris for two years. After that, he completed a four-year clinical fellowship in medical genetics at the University Hospital of Angers, followed by a two-year postdoctoral research position at Columbia University in New York. His areas of interest include congenital malformations, hereditary deafness, autism spectrum disorders, and exome sequencing. His research experience focuses on monogenic diseases, with a particular emphasis on undiagnosed rare diseases. Dr. Ziegler has contributed to significant discoveries in medical genetics. Notably, he participated in an international study that identified de novo variants of the LMBRD2 gene associated with developmental delays, motor impairments, brain structure anomalies, and dysmorphic features. Additionally, he was involved in the discovery of a new gene, IPO8, responsible for a genetic form of aortic aneurysm. Currently, Dr. Ziegler is a contract practitioner in medical genetics at the University Hospital of Toulouse. He supports the LMBRD2 collective and is committed to advancing research on this condition.